Renal Medullary Carcinoma: a Report of the Current Literature
Authors:
- 17 January 2019
- journal article
- research article
- Published by Springer Nature in Current Urology Reports
- Vol. 20 (1) , 4
Abstract
We present an updated report of renal medullary carcinoma (RMC), a rare and aggressive condition.Keywords
This publication has 51 references indexed in Scilit:
- Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature ReviewClinical Genitourinary Cancer, 2018
- Autologous stem‐cell transplant for metastatic renal medullary carcinomaPediatric Blood & Cancer, 2018
- Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic ChallengesAnticancer Research, 2018
- Renal medullary carcinoma: a nearly fatal malignancy specifically affecting patients with a so-called benign conditionCEN Case Reports, 2018
- Renal Medullary Carcinoma: Establishing Standards in PracticeJournal of Oncology Practice, 2017
- Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative studyBJU International, 2016
- Renal medullary carcinoma and sickle cell trait: A systematic reviewPediatric Blood & Cancer, 2015
- Malignant renal tumors in childrenJournal of Kidney Cancer, 2015
- 2004 WHO Classification of the Renal Tumors of the AdultsEuropean Urology, 2006
- Renal Medullary Carcinoma The Seventh Sickle Cell NephropathyAmerican Journal of Surgical Pathology, 1995